OAC
LLY icon

OMERS Administration Corp’s Eli Lilly LLY Stock Holding History

OMERS Administration Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231M Sell
251,586
-78,985
-24% -$80.1M 1.49% 10
2025
Q4 		$355M Sell
330,571
-47,767
-13% -$45.7M 2.53% 8
2025
Q3 		$289M Buy
378,338
+90,402
+31% +$67.3M 2.07% 10
2025
Q2 		$224M Buy
287,936
+128,369
+80% +$99.8M 1.76% 12
2025
Q1 		$132M Buy
159,567
+120,895
+313% +$101M 1.15% 29
2024
Q4 		$29.9M Buy
38,672
+2,015
+5% +$1.67M 0.26% 50
2024
Q3 		$32.5M Buy
36,657
+100
+0.3% +$89.9K 0.3% 52
2024
Q2 		$33.1M Buy
+36,557
New +$29.2M 0.32% 48
2019
Q2 		– Sell
-10,970
Closed -$1.48M – 440
2019
Q1 		$1.48M Buy
+10,970
New +$1.33M 0.02% 177
2018
Q4 		– Sell
-89,700
Closed -$9.63M – 270
2018
Q3 		$9.63M Sell
89,700
-6,200
-6% -$620K 0.09% 68
2018
Q2 		$8.18M Buy
95,900
+14,500
+18% +$1.19M 0.08% 85
2018
Q1 		$6.3M Buy
81,400
+19,900
+32% +$1.6M 0.06% 132
2017
Q4 		$5.19M Buy
+61,500
New +$5.23M 0.05% 166
2016
Q3 		– Sell
-17,900
Closed -$1.41M – 628
2016
Q2 		$1.41M Sell
17,900
-22,100
-55% -$1.66M 0.03% 289
2016
Q1 		$2.88M Buy
40,000
+21,700
+119% +$1.64M 0.06% 177
2015
Q4 		$1.54M Buy
+18,300
New +$1.52M 0.04% 231
2015
Q1 		– Sell
-632,250
Closed -$43.6M – 447
2014
Q4 		$43.6M Sell
632,250
-271,200
-30% -$18.3M 1.32% 20
2014
Q3 		$58.6M Buy
903,450
+750
+0.1% +$47.5K 1.75% 11
2014
Q2 		$56.1M Sell
902,700
-182,800
-17% -$10.9M 1.82% 13
2014
Q1 		$63.9M Buy
+1,085,500
New +$60.6M 2.07% 12
2013
Q4 		– Sell
-5,100
Closed -$257K – 305
2013
Q3 		$257K Hold
5,100
– – 0.02% 137
2013
Q2 		$251K Buy
+5,100
New +$278K 0.02% 133

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OMERS Administration Corp's LLY Position: Q1 2026 in Review

OMERS Administration Corp reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $80.1M and leaving 251,586 shares worth $231M. The position accounts for 1.49% of the portfolio, ranked #10.

OMERS Administration Corp first reported a position in LLY in Q2 2013 and has held it in 22 quarters since. The position peaked at $355M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • OMERS Administration Corp held 251,586 shares of Eli Lilly worth $231M as of Q1 2026.
  • OMERS Administration Corp sold 78,985 Eli Lilly shares in Q1 2026, an estimated $80.1M.
  • Eli Lilly made up 1.49% of OMERS Administration Corp's portfolio in Q1 2026, its #10 holding.
  • OMERS Administration Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 22 quarters since.
  • OMERS Administration Corp's Eli Lilly position peaked at $355M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.